Photobiomodulation for Myofascial Pelvic Pain
Unknown statusNot applicableNCT05926752
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this clinical trial is to evaluate the efficacy of photobiomodulation of the pelvic floor muscles in female Veterans with chronic pelvic pain. The main questions it aims to answer are: * Is there a difference in reduction in overall pelvic pain between women who undergo photobiomodulation compared to women who received pelvic floor physical therapy? * Is there a difference in compliance with therapy between the two groups? Participants will be randomized to treatment with either 9 treatments of photobiomodulation (two treatments per week) or 8 weeks of pelvic floor physical therapy (one treatment a week). Researchers will compare both groups to see if there is a difference in overall pelvic pain reduction.
Study details
- Official title
- Photobiomodulation Therapy for Myofascial Pelvic Pain: A Randomized Clinical Study
- Conditions
- Pelvic Pain
- Levator Ani Syndrome
- Spastic Pelvic Floor Syndrome
- Chronic Pelvic Pain Syndrome
- Myalgia of Pelvic Floor
- Interventions
- Device: SoLá therapy
- Other: Pelvic floor physical therapy
- Sponsor
- Orlando VA Medical Center
- Start date
- 2021-10-27
- Primary completion
- 2024-02-01
- Sex
- Female
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Clinically diagnosed MFPP * Age ≥ 18 * Able to provide informed consent * English speaking * Agree not to participate in any other form of treatment of myofascial pelvic pain for 3 months after end of trial Exclusion Criteria: * Prior pelvic floor physical therapy or SoLá therapy for pelvic pain * Pregnancy documented by urine or blood * Taking drugs that have heat- or light- sensitive contraindications * Reporting decreased sensation in the vagina or rectum or if they are found to have abnormalities on the external neurosensory exam of the vagina * Have a known history of cancer of the cervix, vagina, uterus, bladder, or vulva or suspected to have neoplasia or pre-cancerous lesions * Have an active infection of the bladder, vagina, vulva, or urethra * Have active vaginal bleeding or blood in the vaginal canal * Have evidence of active vaginal trauma, ulcerations, erosions, or other evidence of vaginal and vulvar skin breakdown * Cannot tolerate vaginal examination either due to discomfort, pain or history or traumatic experience
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05926752